<DOC>
	<DOCNO>NCT00333372</DOCNO>
	<brief_summary>To Evaluate efficacy Z-338 subject Functional Dyspepsia , focus assessment subjective symptom order determine optimal dosage efficacy parameter PhaseIII clinical trial .</brief_summary>
	<brief_title>To Evaluate Efficacy Z-338 Subjects With Functional Dyspepsia</brief_title>
	<detailed_description />
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<criteria>Postprandial fullness , upper abdominal bloating and/or early satiety least moderate 2 day 7 day Visit 1 upper abdominal pain , upper abdominal discomfort , postprandial fullness , upper abdominal bloating , early satiety , nausea , vomit belch least moderate least 2 symptom 2 day 7 day Visit 1 subject taht heartburn bothersome symptom Subjects present primary complaint relieve stool movement ( IBS ) Subjects diabetes treatment Subjects taht heartburn moderate</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>